1Goldman AP, Delius RE, Deanfield JE, et al. Pharmacologic control of pulmonary blood flow with inhaled nitric oxide after the fenestrated Fontan operation. Circulation, 1996, 94(Suppl II):II44-48.
2Rossaint R, Falke KJ, Lopez F, et al. Inhaled nitric oxide for the adult respiratory distress syndrome. New Engl J Med, 1993,328:399-405.
3Rocira I,Chen TY, Winkler M, et al. Effects of inhaled nitric oxide on pulmonary hemodynamics and gas exchange in an ovine model of ARDS. J Appl Physiol,1994,76:345-355.
4Foubert L, Fleming B, Latimer R, et al. Safety guidelines for the use of nitric oxide. Lancet,1992,339:1615-1615.
6Kosh S, KumarRK, Gurur ja RS et al. Novel repair for obstructed total anomalous pulmonary venous connection to coronary sinus. Ann Thorac Surg, 2005, 79:711-713.
7Haneda K. Late results after corlrection of ventricular septal defect with servere pulmonary hypertension Tohoku J Exp Med. 1994,174:41-48.
8Keneth M, Hemodynamic effects of PGE1 In Paltents with congenital heart disease and Pulmonary. Hypertension. Cath and cardiovascular diagnosis, 1991,24:15-159.
9Kadosaki M, Kawamura T, Oyama K, et al. treatment for pulmonary hypertensive infants [ J ]. Anesthesiology,2002,96 (4) : 835 - 840.
10Usefulness of nitric oxide during cardiac anesthesia Day RW, Hawkins JA, McGough EC,et al. Randomized controlled study of inhaled nitric oxide after operation for congenital heart disease [J]. Ann Thorac Surg,2000,69 (6) : 1907 - 1912.
